Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Acute Respiratory Distress Syndrome
NCT05914454Phase 2Unknown
- Sponsor
- Azienda Ospedaliero-Universitaria di Udine
- Start
- May 2023
- Primary completion
- Jun 2025
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in acute respiratory distress syndrome (ARDS), sponsored by Azienda Ospedaliero-Universitaria di Udine. Status: unknown.
02
Drugs
anakinra
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT05914454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05914454.